Marco Moscarelli1, Alfredo Cerillo2, Thanos Athanasiou3, Pierandrea Farneti2, Giacomo Bianchi2, Rafik Margaryan2, Marco Solinas2. 1. Pasquinucci Hospital, Ospedale del Cuore, Fondazione Monasterio, Massa, Italy NHLI, Imperial College of London, London, UK m.moscarelli@imperial.ac.uk. 2. Pasquinucci Hospital, Ospedale del Cuore, Fondazione Monasterio, Massa, Italy. 3. Department of Surgery and Cancer, Imperial College, Paddington, London, UK.
Abstract
OBJECTIVES: (i) To establish who is at high risk for mitral surgery. (ii) To assess the performance of minimally invasive mitral valve surgery in high-risk patients by presenting early and late outcomes and compare these with those of the non-high-risk population. METHODS: We reviewed our database of prospective data of 1873 consecutive patients who underwent minimally invasive mitral surgery from 2003 to 2015. To establish an unbiased definition of risk cut-off, we considered as high-risk the 'outliers of risk' identified using boxplot analysis in relation to EuroSCORE II. RESULTS: Two hundred and five patients were outliers, with 98 as minor (EuroSCORE II ≥ 6%) and 107 as major outliers (EuroSCORE II ≥ 9%). Outliers accounted for several different comorbidities. Nineteen patients died while in hospital (9.2%); different postoperative complications were observed. Outliers had a significantly lower mean survival time and a higher risk of cardiac-related death than the general population; however, the worst outcomes were observed in major outliers. No statistically significant difference was found with regard to the need for mitral reintervention and the degree of mitral regurgitation at follow-up. CONCLUSIONS: Boxplot analysis helped to achieve an internal definition of risk cut-off, starting from EuroSCORE II ≥ 6%. Minimally invasive mitral surgery in these outliers of risk was associated with acceptable early and long-term results; however, major outliers with EuroSCORE II ≥ 9% may benefit from catheter-based procedures.
OBJECTIVES: (i) To establish who is at high risk for mitral surgery. (ii) To assess the performance of minimally invasive mitral valve surgery in high-risk patients by presenting early and late outcomes and compare these with those of the non-high-risk population. METHODS: We reviewed our database of prospective data of 1873 consecutive patients who underwent minimally invasive mitral surgery from 2003 to 2015. To establish an unbiased definition of risk cut-off, we considered as high-risk the 'outliers of risk' identified using boxplot analysis in relation to EuroSCORE II. RESULTS: Two hundred and five patients were outliers, with 98 as minor (EuroSCORE II ≥ 6%) and 107 as major outliers (EuroSCORE II ≥ 9%). Outliers accounted for several different comorbidities. Nineteen patients died while in hospital (9.2%); different postoperative complications were observed. Outliers had a significantly lower mean survival time and a higher risk of cardiac-related death than the general population; however, the worst outcomes were observed in major outliers. No statistically significant difference was found with regard to the need for mitral reintervention and the degree of mitral regurgitation at follow-up. CONCLUSIONS: Boxplot analysis helped to achieve an internal definition of risk cut-off, starting from EuroSCORE II ≥ 6%. Minimally invasive mitral surgery in these outliers of risk was associated with acceptable early and long-term results; however, major outliers with EuroSCORE II ≥ 9% may benefit from catheter-based procedures.
Authors: Samer A M Nashef; François Roques; Linda D Sharples; Johan Nilsson; Christopher Smith; Antony R Goldstone; Ulf Lockowandt Journal: Eur J Cardiothorac Surg Date: 2012-02-29 Impact factor: 4.191
Authors: Joerg Seeburger; Michael A Borger; Volkmar Falk; Jurgen Passage; Thomas Walther; Nicolas Doll; Friedrich W Mohr Journal: Ann Thorac Surg Date: 2009-03 Impact factor: 4.330
Authors: Pavan Atluri; Y Joseph Woo; Andrew B Goldstone; Jeanne Fox; Michael A Acker; Wilson Y Szeto; W Clark Hargrove Journal: Ann Thorac Surg Date: 2013-08-27 Impact factor: 4.330
Authors: Paul Tang; Mark Onaitis; Bhargavi Desai; Jeffrey G Gaca; Carmelo A Milano; Mark Stafford-Smith; Donald D Glower Journal: Innovations (Phila) Date: 2013 Sep-Oct
Authors: Damien J LaPar; James M Isbell; Ivan K Crosby; John Kern; D Scott Lim; Edwin Fonner; Alan M Speir; Jeffrey B Rich; Irving L Kron; Gorav Ailawadi Journal: Ann Thorac Surg Date: 2014-10-03 Impact factor: 4.330